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1. Introduction
Median sternotomy due to its technical simplicity and excellent exposure of the heart, great
vessels and pulmonary hila is the most common incision performed in cardiothoracic surgery
worldwide [1]. Originally described by Julian more than 100 years ago and re-induced by
Milton in 1957, median sternotomy replaced gradually thoracotomy or bilateral transverse
sternothoracotomy (clamshell incision) for routine access to the heart [2,3]. Even though
median sternotomy is still considered to be the gold standard, efforts remain ongoing to use
less invasive methods such as partial sternotomy or small thoracotomy to influence the risk of
wound healing complications, patient’s satisfaction and better quality of life [4].
2. Incidence and risk factors of Deep Sternal Wound Infection (DSWI)
Infection involving the sternal bones and/or retrosternal space is a serious complication of
median sternotomy. Although, DSWI can be described from many perspectives, the definition
according to the Center for Disease Control and Prevention (CDC), is used for distinguishing
DSWI from others types of sternal wound infections (SWIs), and is respected by most authors
(Table 1) [5]. Looking through the incidence of DSWI ranging between 0.3 to 3.2%, no consid‐
erable changes have been observed in the incidence of DSWI over the last 30 years [6-22]. It
could be perceived that the numerous advances in cardiac surgery, post-operative care and
employment of preventive measurements may have played a role in reducing the incidence
of DSWI in the last 10 years. Today surgically treated patients’ cohorts are different than
patients operated on 20 years ago in terms of advanced age, co-morbidities, and surgical
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complexity. In other words, the relatively steady status of DSWI incidence over the last three
decades might be considered a satisfactory result [23]. Recently Matros et al showed from a
large single institution experience with 21,000 sternotomies a reduction in the incidence of
DSWI from 1.57 to 0.88% in the last 15 years. They concluded that the rate of DSWI was
significantly diminished particularly in the diabetic population, from 3.2% to 1.0%, related to
tight glycemic control [19].
Diagnosis of DSWI requires at least one of the following criteria:
(1) anorganism is isolated from culture of mediastinal tissue or fluid
(2) evidence of mediastinitis is seen during operation or byhistopathological examination
(3) one of the following, fever("/>38º C), chest pain, or sternal instability, is present
and there is either purulent drainage from the mediastinum
or an organism isolated from blood culture or culture of drainage of the mediastinal area
Table 1. Center for Disease Control and Prevention (CDC) criteria of DSWI (modified from Mangan et al[5])
The identification of risk factors for the development of DSWI is crucial in the effort to reduce
the risk of infection [6-22]. Although more than two dozen factors were obtained for uni-, and
multivariable analyses, only obesity and diabetes mellitus were constantly proven in publish‐
ed studies [6-18,21,22]. Obesity is a strong risk factor for development of DSWI. Even though
BMI does not correlate closely with body fat, there is a step-wise relationship between BMI
and the risk of major surgical infection in cardiac surgery [7,15,24]. It is caused not only through
technical obesity-related problems, but also through less effective penetration of antibiotics
into the fat tissue [24]. Undoubtedly, diabetics are at a higher risk of developing DSWI, making
the role of perioperative glycemic control crucial. Unsatisfactory preoperative glycemic control
is considered to be an important risk factor for development of DSWI [25,26]. Internal mam‐
mary artery (IMA) harvesting, particularly in the pedicled fashion, has been found to have a
higher incidence of DSWI in a CABG cohort compared with valvular procedures [7,8].
Furthermore, this risk becomes stronger when both IMA are used for revascularization or in
the diabetic population, but this effect might be attenuated when both IMA are taken down in
a skeletonized fashion, even in diabetics [10,27,28]. Chronic obstructive pulmonary disease
(COPD) or smoking increases the risk of infectious complications, prolonged post-operative
ventilation, and jeopardizes sternal stability from excessive coughing [6,12,15]. Data address‐
ing the impact of early tracheostomy on DSWI incidence is conflicting [29-31]. Historically, a
strong relationship between early tracheostomy and DSWI has not been confirmed; but
tracheostomy is known to reduce the need for mechanical ventilation and thereby may limit
risk of pulmonary infection and ICU stay [32]. Furthermore, re-exploration for bleeding has
been analyzed as an independent risk factor for DSWI in several studies [11,12]. The compo‐
nents of this risk factor include the risk of iatrogenic bacteriological wound contamination
within the inherent re-exposure, the deleterious effect of anemia and/or concomitant hemo‐
dynamic instability, and the amount of given allogenic blood transfusion units [10,33]. Other
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factors traditionally associated with an increased risk of DSWI are inconsistently seen in
analyses of retrospective studies including advanced age, emergency surgery, hemodynamic
instability, low ejection fraction, duration of surgery and CPB time, and renal failure [6-22].
Incidence and risk factors based on multivariable analysis from larger retrospective studies
are summarized in Table 2.
Authors Patients´
enrollement
No. of
patients
DSWI
incidence
Independent risk factors
Loop FD et al [6] 1985-1987 6504 1.1% Obesity, BIMA+diabetes, time of operation,
Milano CA et al [7] 1987-1995 6459 1.3% Obesity, CHF, re-do surgery, CPB time
Braxton et al [8] 1992-1996 15406 1.25% Obesity, low EF, COPD
Eklund et al [9] 1990-1999 10713 1.1% Obesity, BMI
The Parisian Mediastinitis
Study Group [10]
1996 1830 NA Obesity, BIMA, hemodynamic instability, re-
do surgery
Hollenbeak et al [11] 1996-1998 1519 2.7% Obesity, renal inssuficieny, re-exploration
Filsouri et al [12] 1998-2005 5798 1.80% Obesity, MI, diabetes, COPD, CPB time, re-
exploration, prolonged ventilation
Tang et al [13] 1990-2003 30102 0.77% Age, diabetes, stroke, CHF, BIMA
+diabetes/CHF
Toumpoulis et al [14] 1992-2002 3760 1.1% Diabetes,dialysis, hemodynamic instability,
BIMA
Risnes et al [15] 1989-2000 18532 0.6% Age, male gender, obesity, COPD, diabetes
Crabtree et al [16] 1996-2003 4004 2.2% Obesity, diabetes,"/>2 transfusion units
Fowler et al [17] 2002-2003 331429 NA Obesity, diabetes, MI, urgent surgery
Sjoegren et al [18] 1999-2004 4781 0.95% Diabetes, obesity, low EF, renal failure
Matros et al [19] 1991-2006 21000 1.35% Prolonged CPB time
De Feo et al [20] 1979-2009 22366 0.89% NA
Upton et al [21] 1998-2003 5176 1.2% Diabetes, urgent surgery, low EF
Sachithanandan et al [22] 2001-2005 4586 1.65% Diabetes, smoking, age, prolonged
ventilation
NA - not adrressed
BIMA - bilateral IMA harvesting
EF - ejection fraction
COPD - chronic obstructive pulmonary disease
CHF - congestive heart failure
MI - myocardial infaction
Table 2. Analyses of incidence and risk factors of DSWI
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3. Microbiology of DSWI and routes of infection
Staphylococci, either S. aureus (SA) or coagulase-negative Staphylococcus (CONS) represent
the most causative organism of DSWI, accounting for 60 to 80% of cases [34]. The proportion
of individual strains of Staphylococcus and their methicillin-sensitivity varies between
countries and institutions, reflecting their long-term hygienic and antibiotic policies [35].
Although surgical site infections are typically perceived to be an exogenous problem related
to exposure to healthcare workers, the most causative pathogens are endogenous from
patient’s own skin or mucosal flora [36,37]. Nasal carriage of SA has been identified as a
potential risk factor for DSWI [38], and genetically identical SA from nasal flora have been
cultivated from sternotomy wounds [39]. Unlike SA which caused a more aggressive presen‐
tation, CONS infection accompanied with bacteremia as observed in 50-60% of cases [34, 40]
had a rather indolent course, clinically manifested later, and was more prone to recurrence [41,
42]. DSWI is diagnosed in 40-70% of patients post-discharge, thus post-discharge surveillance
of up to 90 days is recommended [43]. Gram negative strains contribute less commonly in the
pathogenesis of DSWI and mostly translocate from other host site infections, such as pneu‐
monia, urinary or abdominal infections [34]. Finally, no significant difference in mortality was
observed between DSWI infections caused by CoNS, when compared to SA, or Gram-negative
pathogens [34]. Mekontso-Dessap et al suggested that DSWI caused by methicillin-resistant
SA (MRSA) may have worse actuarial survival than sensitive strains (MSSA) in terms of 1
month, 1-year, and 3- year survival (60.0%±12.6%, 52.5%±-3.4%, and 26.3%±19.7% versus 84.6%
±7.1%, 79.0%±8.6%, and 79.0%±-8.65, p=0.04), and a regression analysis revealed MRSA as an
independent risk factor for overall mortality [44].
4. Outcomes and cost of DSWI
Unsurprisingly, DSWI negatively affected outcomes in cardiac surgery. Even with the
adoption of modern treatment strategies, the reported in-hospital mortality for DSWI varies
from 1.1 to 19% [6-9,11,16,45]. Although the mortality rate is similar to data reported from the
1980s, it appears that implementation of negative pressure wound therapy (NPWT) may
improve long-term survival of patients [18,20,46]. Regardless of treatment strategy, in-hospital
stay of DSWI patients is at least two weeks longer compared to patients with an uncomplicated
post-operative course [6,10,11]. DSWI-related morbidity was repeatedly reported in relation
to prolonged mechanical ventilation, renal impairment, atrial and ventricular arrhythmias,
cerebrovascular accidents, need for hemodynamic support, and healing-related complications
[20,47]. The cause of death in the early post-operative period is mostly multiple organ failure
initiated by sepsis or specific DSWI-related complications such as serious bleeding [6-8,16,18,
20]. Predictors of a poor outcome in DSWI patients that have been reported include length of
intensive care unit (ICU) stay, late indication for surgical revision, bacteremia, hemodynamic
instability, and prolonged mechanical ventilation [47,48]. Loop et al presented the worse
survival data of DSWI in patients operated on during the 1980s in comparison with a standard
CABG population within a 3-year follow-up after surgery [6]. Survival analyses published in
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the last decade consistently confirm long-term complications of patients with mid-, and long
term survival rates who were successfully treated for DSWI (Table 3) [8,11,12,14,15,18,22,46].
Specific reasons for worsening of long-term survival are not yet clear. Risnes et al reported
significantly higher cardiac-related deaths in the post-DSWI group (34.6 vs. 21.4%, p<0.006)
and poorer survival for males ten years after surgery [15]. In contrast with this data, Sjoegren
et al and Bailot et al showed unimpaired long-term survival of DSWI patients in comparison
with patients who had uncomplicated surgery once NPWT was used [18,46].
Authors Patients´
enrollement
Survival analysis
Loop FD et al [6] 1985-1987 3-year survival of 62.5% compared to 69.0% survival for patients with positive
cultures. Overall, the 3-year survival was 75%, which is significantly below
previously reported 5-year and even 10-year survival for isolated coronary bypass
patients
Braxton et al [8] 1992-1996 The adjusted survival rates at 30 days, 1 year, and 4 years were 93%, 78%, and 65%
among patients with mediastinitis and 97%, 95%, and 89% without mediastinitis,
respectively (p<0.001)
Hollenbeak et al
[11]
1996-1998 DSWI patient had a 1-year survival of 78% vs. 99% for non-infected CABG patients,
p=0.0001
Filsouri et al [12] 1998-2005 Survival rates at 1,3, and 5 years were 72.4%, 64.3% and 55.8% for patients with
DSWI compared with 93.8%, 88% and 82% for the control (p<0.001)
Toumpoulis et al
[14]
1992-2002 Freedom from all cause mortality in patients in whom DSWI developed at 1 year, 5
years, and 10 years after the operation was 66.2%, 50.8%, and 40.6% respectively,
compared with 87.2%, 72.8%, and 54.3% in patients without DSWI (p=0.0007)
Risnes et al [15] 1989-2000 The 10-year, long-term survival for patients with mediastinitis was 49.5%,
compared with 71.0% in non-mediastinitis patients (p<0.01)
Sjoegren et al [18] 1999-2004 The actuarial survival at 1 year, 3 years, and 5 years was 92.9% , 89.2%, and 89.2%
for patients with mediastinitis and 96.5%, 92.1%, and 86.9 for those without
mediastinitis(p=0. 578)
Sachithanandan
et al [22]
2001-2005 Unadjusted freedom from all-cause mortality in patients with DSWI at 1 year, 2
years, and 3 years after surgery was 78.6 ± 4.8% (95% CI 69–88.2%), 75.6 ± 5.0%
(95% CI 65.6–85.6%) and 69.4 ± 5.8% (95% CI 57.8–81%) respectively compared
with 92.8 ± −0.4% (95% CI 92.4–93.2%), 90.7 ± 0.5% (95% CI 90.2–91.2%) and
87.7 ± 0.6% (95% CI 87.1–88.3%) for patients without DSWI (p < 0.001)
Bailot et [46] 1992-2007 Survival in patients with DSWI showed freedom from all-cause mortality at 1, 5 and
10 years to be, respectively, 91.8%, 80.4% and 61.3% compared with 94.0%, 85.5%
and 70.2%, respectively, for patients (p = 0.01). Adjusted survival for patients with
DSWI treated with NPWT was 92.8%, 89.8% and 88.0%, respectively, at 1, 2 and 3
years, compared with 83.0%, 76.4% and 61.3%, respectively, for patients with
DSWI treated conventionaly(p = 0.02)
Table 3. Analyses of compared mid-term and long-term survival of patients with DSWI with non-DSWI patients
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Patients who develop DSWI are 2.5 to 3 times more expensive to manage compared with
patients who have an uncomplicated post-operative course [6,11]. The first calculation of cost
originated from the Loop et al paper, published in the late 1980´s, and found a 2.8 times increase
in cost [6]. Patients who died of DSWI consequences consumed 60,500 USD more, making the
total cost of these patients approximately 80,000 USD compared with 11,000 USD an uncom‐
plicated CABG patient cost, as showed by Hollenbeak et al [11]. Recent data from Germany
showed a doubling in cost (36,261 vs. 13,356 EUR, p<0.001) for DSWI patients [49], while
Ennker et al calculated a 9,000 EUR increase in cost on average for any DSWI case [50]. The
majority of the increased cost is spent on repeat surgical and ICU service, and extension of in-
hospital stay [11,51,52]. In looking for cost-effectiveness of treatment strategies, NPWT does
not seem to be a more expensive treatment in comparison with the conventional therapy for
DSWI, as calculated in the Swedish healthcare system by Mokhari et al [52]. Atkins et al
reported lower NPWT costs than Medicare charges for conventional therapy (152,000 vs.
300,000 USD) of DSWI [53].
5. Strategies preventing DSWI
As mentioned previously, diabetes mellitus is a strong independent risk factor for develop‐
ment of DSWI, and concomitant obesity doubles the risk of further infection [24]. Unfortu‐
nately, both risk factors are difficult to modify. Zerr et al showed that a continuous insulin
infusion started immediately after surgery to maintain a serum glucose level of 150-200mg/dl
(8-11 mmol/l) led to a significant decrease in the incidence of DSWI in diabetics (2.4% to 1.5%,
p < 0.02) compared with subcutaneously administered insulin [54]. A tight glycemic control
protocol appears beneficial from the Portland group experience, nevertheless, decreasing
serum glucose below 100mg/dl (6 mmol/l) did not bring any additional impact on DSWI rate,
and was associated with a higher risk of stroke or death [55].
It has been demonstrated many times that antibiotic prophylaxis effectively prevents sternal
wound infection [56]. As Staphylococcal stains are a major causative pathogen, beta-lactam
antiobiotics are recommended for prophylaxis, particularly first or second generation cepha‐
losporins [57]. The use of glycopeptides, which are highly effective against MRSA, has not
been linked with a reduction in sternal wound infection rates compared to standard prophy‐
laxis, with one study suggesting higher SSI´s rate (3.7 vs. 1.3%, p<0.05) when vancomycin
prophylaxis was chosen [58]. Local application of a gentamicin soaked-collagen sponge
between the sternal lamella was suggested to reduce all SWI´s, particularly DSWI. Friberg et
al reported a significant reduction in SWI´s (3.7 vs. 9%, p<0.001), and also DSWI (1.5 vs. 3.3%,
p<0.003) [59,60], however, further randomized controlled trials and meta-analyses did not
confirm a benefit of using a gentamicin sponge for DSWI prevention as well as a recently
published meta-analysis [61,62]. Although SA caused DSWI might be reduced by locally
applied gentamicin, primarily gentamicin-resistant strains such a CONS may overgrow [62].
Another prophylactic issue is patient decontamination before surgery. As Staphylococci
colonization is seen in a majority of DSWI, skin and nasopharyngeal decontamination became
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popular [38,39]. The use of chlorhexidine for skin care before surgery showed a significant
reduction in the microbial count including SA [63]. In comparison to general surgery where
reduction of SSI´s due to skin decontamination was confirmed [64], data for cardiac surgery
is lacking, nevertheless, protocols involving chlorhexidine or a different skin cleanser are
already widely accepted. Locally applied ointment containing mupirocin is 80 to 90% effective
in eradicating all types of SA from the nasopharyngeal mucosa [65]. Cimochowski et al
reported about the efficacy of this practice on reducing DSWI rates from 2.7% to 0.9% [66]. A
randomized controlled trial published by Konvalinka et al did not confirm a reduced DSWI
rate from the use of nasal mupirocin ointment (0.8 vs. 0.8%) [67].
The surgical technique in performing median sternotomy and its closure certainly influences
the risk of DSWI. Careful handling of skin and pre-sternal soft tissue, mid-lined sternal incision
and avoidance of bone wax are essential, in addition to keeping scrub protocol, checking for
glove injury, changing gloves after sternotomy and after sternal wiring, and leaving the closed
wound primarily covered for at least 48 hours [68].
It has been proposed that the method of IMA harvesting affects the incidence of DSWI,
particularly when both IMA (BIMA´s) are demanded for revascularization [7,8,10,27,28]. A
recent meta-analysis published by Saso et al showed a reduced risk of SWI´s once IMA or
BIMA´s were harvested in a skeletonized fashion compared with a pedicled graft. The risk was
reduced both in the non-diabetic (2.96% vs. 11.7%) and diabetic populations (2.4% vs. 14.2%)
[69]. Besides harvesting methods of BIMA´s in diabetics, as was mentioned above, tight long-
term glycemic control influenced the risk of DSWI. A hemoglobin A1c (HbA1c) ≥7% had a
higher incidence of DSWI compared with patients who had a HbA1c <7% (5.0% vs. 1.4%, P =
0.014). A 31% increased risk of DSWI (OR = 1.31, 95% CI 1.16-1.49, P < 0.001) was seen by Halkos
et al [26]. Even through diabetic patients may have a comparable risk of developing DSWI
when IMA in skeletonized fashion is taken down, the BIMA´s harvesting need is to be
considered carefully because additional risk factors such an obesity and COPD are commonly
presented in this cohort [24,70].
The crucial point in preventing DSWI is achievement of stable sternal approximation. Standard
sternal wire cerclage, if performed well, is fast, easy and effective [71]. Facing poor sternal
quality, sternal fracture, or increased traction forces in obese or COPD patients, some modifi‐
cations of this technique were proposed. Parasternal wire reinforcement, described originally
by Robicsek and modified by Sharma, proved to reduce the risk of sternal wound complica‐
tions [72,73]. Friberg et al reported that the use of more than 6 or 7 simple wires may also
reduce DSWI rates (0.4% vs. 4.2%, p=0.001) [74]. Recently, a large multicenter prospective study
conducted by Schimmer et al comparing the Robicsek technique with standard cerclage failed
to reduce the risk of SWI and sternal dehiscence [75]. Primary plating, mirroring the experience
in maxillofacial surgery, was proposed for patients at high risk of sternal non-union [76]. Plates
could be anchored only into the sternal bone (SternaLock system™,Biomet Microfixation Inc,
Jacksonville, US) or into the ribs (Titanium Sternal Fixation system™, Syntes, Switzeland).
Raman et al reported better chest bone healing after primary plating than rewiring at 6-month
follow up (70 vs. 24%, p=0.003) and lower pain scores, with no difference in SWI rates [77].
Others systems are used for sternal approximation including, thermoreactive nitinol clips
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(Flexigrip™, Praesidia SRL, Bologna, Italy), titanium locked staples (Sternal Talon™, KLS
Martin Group, US), and Poly-Ether-Ether-Ketone tapes (Sternal ZipFix system™, Syntes,
Switzeland), all designed for parasteral fixation. Negri et al reported a significant reduction of
mechanical dehiscence (2.8% vs. 0.2%, p=0.002), but the same risk of DSWI (1.2% vs. 2.4%)
when thermoactive clips were compared with standard wire cerclage [78]. Snyder et al
reported 5 years of experience with the SternaLock system™ for primary plating in high risk
patients. Superiority of plate over wires was seen in the incidence of early presentation (<30
days) of SWI (0% vs. 12%, p<0.06) and shorter in-hospital stay (7 vs. 8 days, p=0.02) [79]. A
pilot study published by Bennett-Guerrero et al showed insignificantly higher spirometry
volume in the SternalTalon™ arm (67% ± 32%) versus the wire arm (58% ± 24%). Use of the
Talon was associated with decreased use of opiates (21.3 ± 11.8 vs. 25.4 ± 21.6 mg, P = 0.44),
duration of mechanical ventilation (0.5 vs. 1.0 days, P = 0.24) and hospital length of stay (4.5 ±
3.2 vs. 5.3 ± 4.0 days, P = 0.40) [80].
A promising method to reduce SSI seems to be the application of NPWT on surgically closed
sternal wounds. A commercially available system (Prevena® Incision Management System,
KCI, St. Antonio, USA) is used, with skin preservation through a semipermeable membrane
that has contact with foam, and one proposal pump system with reservoir is added [81].
Limited clinical experience has shown a decreased risk of wound hematoma, seroma and SSI
[82]. Other positive effects from wound application of NPWT might include promotion of
microvascular flow and decreased tissue edema and myofibroblast activation [83]. Colli and
Atkins et al reported no wound healing complications in patients at high risk for sternal wound
infections after cardiac surgery, but both studies were retrospective and done on smaller cohort
of patients, 10 and 57, respectively [84,85].
6. Treatment strategies for DSWI
Even though treatment of DSWI has considerably evolved, a generally accepted treatment
strategy remains controversial. Robicsek postulated three valid principles addressing this
issue: first, that the infectious process should be brought under control within the shortest
possible time, secondly, that adequate debridement and drainage of the infected area should
occur, and third that sternal stability should be assured [86]. Until the 1960s, patients suffering
from DSWI were treated conservatively with antibiotic therapy, limited drainage, or exposure
of the sternotomy wound until closure with granulation tissue occurred [87]. Mortality rates
then reached over 50% and survivors’ quality of life was limited due to significant morbidity
[87]. In 1964, Shumacker and Mandelbaum reported their experience with single-stage
technique of wound debridement, primary sternal re-wiring and continuous antibiotic
irrigation [88]. Their original method was consequently modified in terms of the type of
antibiotic or antiseptic solution used including its amount, or the setting of indwelling drains
for irrigation and suction [89-90]. Closed chest drainage became widely used with reported
mortality from DSWI ranging from 4.8% to 28%, with an associated risk of primary therapy
failure ranging from 12.5% to 48% [89,90-92]. Lee et al proposed in 1976 the use of an omental
flap for covering infected sternotomy wounds [93]. Vital greater omentum was turned into the
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chest cavity following sternal debridement. It was suggested that well-vascularized omentum
fulfills dead spaces, ensures high antibiotic levels, and yielded angiogenic and absorptive
capacity [13,93]. Jurkiewicz et al first reported the use of muscle flaps, preferably the pectoralis
flap, and radical sternal debridement in the treatment of DSWI in 1980 [94]. Consequently, 20-
years of experience in the Emory group with 409 patients showed 8.1% in-hospital mortality
and 5.1% primary therapy failure. 87.1% of procedures were done in single-stage fashion; the
pectoralis major was used in 76.6%, rectus abdominis in 19.4%, and omentum in 2.2% [95].
This approach has received many modifications regarding the timing of wound closure, choice
of flap, and type of advancement, with reported mortality ranging from 0% to 19% [96,97].
Comparing the omental to the pectoralis flap, Milano et al reported that the omental flap had
lower mortality (4.8% vs. 10.5%, p<0.05), early wound related complications (9.5% vs.
27.7%,p<0.001), and in-hospital stay (10.7 vs. 18.8%, p<0.05) [98]. El Oakley and Wright
suggested classification of DSWI based on the time of presentation, presence of risk factors
such as obesity, diabetes or immunosuppressive therapy, and number of failed therapeutic
attempts in 1996 (Table 3) [99]. The identification of five subtypes of DSWI seemed to be a
relevant tool for choice of therapeutic method and patient prognosis. Adjusted to the El Oakley
and Wright classification, closed chest irrigation has comparable mortality data for type I and
II DSWI compared with radical sternal resection and concomitant flap, but with lower flap-
related associated morbidity [100-102]. Ringelman et al noted that at 48 month follow-up, 51%
of patients had pain or discomfort, 44% had numbness, 42% complained of sternal instability,
and 33% claimed to have shoulder weakness, when pectoral flap was used for reconstruction
[103]. Closed chest irrigation carries a higher rate of therapy failure when used for type III, and
particularly type IV and V El Oakley and Wright classification [104-107]. Thus, these patients
might have benefit from more radical sternal debridement and employment of well-vascular‐
ized tissue to replenish residual defects. Flap-related morbidity may be addressed with less
invasive techniques such as a laparoscopic greater omentum harvesting [108]. Atkins et al
recently reported on the influence of sternal repair choice (pectoral, omental flap, or secondary
closure) on long-term survival [109].
There is limited data evaluating hyperbaric oxygen (HBO) therapy in the treatment of SWI,
despite theoretical advantages, availability of HTO close to the cardiac surgical unit impedes
its routine use [110]. Siondalski et al reported successful healing of 55 DSWI patients with no
mortality, nevertheless therapy required 20-40 HBO sessions after surgical revision. HTO was
taken as an adjunct therapy to perform radical debridement and muscle flap [111].
Class Description of DSWI
Type I Mediastinitis presenting within 2 weeks after operation in the absence of risk factors
Type II Mediastinitis presenting at 2 to 6 weeks after operation in the absence of risk factors
Type IIIA Mediastinitis type I in the presence of one or more risk factors
Type IIIB Mediastinitis type II in the presence of one or more risk factors
Type IVA Mediastinitis type I, II, or III after one failed therapeutic trial
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Class Description of DSWI
Type IVB Mediastinitis type I, II, or III after more than one failed therapeutic trial
Type V Mediastinitis presenting for the first time more than 6 weeks after operation
Accepted risk factors: diabetes, obesity, immunosupressive therapy intake
Table 4. El Oakley and Wright classification of DSWI (modified from El Oakley et[99])
In 1997, Obdeijin et al described the first application of NPWT for treatment of DSWI in 3
consecutive patients [112]. They found that physical therapy contracted the wound, provided
sufficient chest stability, and allowed patients to be extubated. Catarino et al reported the first
retrospective comparison between NPWT and closed chest irrigation in 2000. In comparing 9
versus 10 patients, they found superiority of NPWT in length of in-hospital stay (15 vs. 40.5 days,
p=0.02) and therapy failure (0 vs. 5, p=0.03) [113]. Furthermore, Gustafsson et al and Fleck et al,
from the two most active European centers (Lund and Vienna), reported similar in-hospital and
30-day or 90-day mortality of DSWI patients, with 60% of all cases having class III according to
El Oakley and Wright [114,115]. Consequently, the Lund group reported survival data from 1,3,
and 5 year follow-up which showed comparable survival (92.9%, 89%, 89%) with patients without
DSWI after CABG (96%,92%, 86%) and showed potential survival benefit of NPWT therapy
unlike data known from conventional therapy [18]. Recently published data from a larger group
of patients showed 1.1-5.4% mortality at 30 days and 8-15% 1 year mortality with a 2 to 6% risk
of primary therapy failure [116-119]. The mean length of application of NPWT was 8 to 14 days
with a mean number of 4 to 6 dressing changes [116-119]. The amount of dressing used by centers
has only minor variability in first-line application protocol, with the only differences reported
being the materials used for interface dressing and the timing of wound closure [116-119]. It was
suggested that low C-reactive protein level (<50 mg/l) might be a good indicator for timing of
wound closure [120]. Since the introduction of NPWT, its comparison with conventional therapy,
closed chest irrigation or sternal resection and flap have been studied. So far, we have data only
from retrospective comparative studies, with the compared arms being heterogeneous in
number of patients, time periods and type of DSWI based on El Oakley classification. It was
suggested that NPWT positively influenced the risk of primary therapy failure and survival of
patients at short and long-term follow-up [18,46,121-138]. Outcomes of NPWT are DSWI
causative pathogen independent, even comparing therapeutic response to MRSA and MSSA
caused DSWI [139]. From multivariable analyses, obesity, renal failure and sepsis were calculated
as independent risk factors of NPWT failure [128,129]. Results of comparative studies and
published meta-analyses are shown in Table 5.
Authors Follow-up Patients
´cohort
Endpoints Results
Catarino et al
[113]
Retrospective 11 pts NPWT
vs. 9 pts closed
irrigation
In-hospital stay, primary
therapy failure
NPWT linked with shorter in-hospital stay (15
vs. 40.5 days, p=0.02) and lower therapy
failure (0 vs. 5%, p=0.03) than closed irrigation
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Authors Follow-up Patients
´cohort
Endpoints Results
Berg et al [121]Retrospective 31 pts NPWT
vs. 29 pts
closed
irrigation
Primary therapy failure,
in-hospital stay and
mortality
NPWT group had a lower risk of therapy
failure (52 vs. 16%, p<0.05) and in-hospital
stay (22 vs. 26 days, p<0.05), with comparable
in-hospital mortality (6,9 vs. 6,6%, NS) to
closed irrigation
Doss et al
[122]
Retrospective 22 pts NPWT
vs. 22 closed
irrigation
Primary therapy failure,
in-hospital stay and
mortality
NPWT group had shorter overall length of
therapy (17.2±5.8 vs. 22.9±10.8 days, p=0.01)
and in-hospital stay (27.9±6.6 vs. 33.0±11.0
dnů, p=0.03), with comparable mortality (5 vs.
5%, NS) to closed irrigation
Song et al
[123]
Retrospective 17 pts NPWT
vs. 18 pts open
packing
Primary therapy failure,
number of dressing
changes, in-hospital
stay and mortality
NPWT associated with shorter length of
therapy ( 6.2 vs. 8.5 days, p<0,05), lower
number of dresssing changes (3±2.5 vs.
17±8.6 , p<0.01), and comparable in-hospital
mortality (11 vs. 6%, NS)
Luckraz et al
[124]
Retrospective 27 pts NPWT
vs. 13 pts
closed
irrigation
Primary therapy failure,
in-hospital mortality,
and cost of therapy
NPWT linked with lower therapeutic failure
rate (15 vs. 30.7%, p<0.05), in-hospital
mortality (7.5% vs. 18.5%, p<0.05) and overall
cost of therapy (16 400 vs. 20 000 USD)
compared with closed irrigation
Fuchs et al
[125]
Retrospective 35 pts NPWT
vs. 33 pts open
packing
Lenght to achieve
sterile woud, length of
therapy, in-hospital
stay, and 1-year survival
NPWT led to faster bacterial decontamination
of wounds (16 vs. 26 days, p<0.01), shorter
length of therapy (21 vs. 28 days, p<0.01) and
in-hospital stay (25 vs. 34 days, p<0.01) and
better 1-year survival (97.1 vs. 74.7%, p<0,05)
compared with open packing
Sjoegren at el
[126]
Retrospective 61 pts NPWT
vs. 40 closed
irrigation/
open packing
Therapy failure, 1- and
5-year mortality
NPWT had lower risk of therapy failure (0 vs.
15%,p<0.01), 90 day mortality (0 vs. 15%,
p<0,01), and 1- and 5-year survival (93 vs.
82%, 83 vs. 59%, p<0.05) against conventional
therapy
Immer et al
[127]
Retrospective 38 pts NPWT
vs. 17
sternectomy
and flap
In-hospital stay and in-
hospital mortality,
quality of life
NPWT led to shorter in-hospital stay
(51.5±20.8 vs. 70.7±28.8 dnů, p<0.05), non-
significantly lower in-hospital mortality (5.3 vs
11.8, NS) and better quality of life based on
questionnaire SF-36 compared with
sternectomy and flap
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Authors Follow-up Patients
´cohort
Endpoints Results
Segers [128] Retrospective 29 pts NPWT
vs. 34 pts
closed
irrigation
Therapy failure, in-
hospital, and 1-year
mortality
NPWT decreased primary therapy failure (27.6
vs. 58.9%, p<0.05), with comparable 30 day
(3,5 vs. 2,9%, NS)and 1-year mortality (31.0 vs.
23.5%, NS) to closed irrigation
Bailot et al [46]Retrospektive
conventional
and prospective
for NPWT
125 pts NPWT
vs. 24 pts.
open packing
In-hospital mortality
and 1-,5-, and 10 years
survival
Lower mortality in NPWT group (4.8 vs. 14.1%,
p=0.01), but insignificantly better 1,5, and 10
year survival(92.8 vs. 83.0%, 89.8 vs. 76.4%,
88.0 vs. 61.3%, NS)
Petzina et al
[129]
Retrospective 69 pts NPWT
vs. 49 closed
irrigation
Primary therapy failure,
in-hospital stay and
mortality
NPWT associated with lower therapeutic
failure (2.9% vs.18.3% p<0.05) and in-hospital
mortality (5.8% vs. 24.5% p<0.05), but
comparable in-hospital stay (38 vs. 41 days,
NS) with closed irrigation
Simek et al
[130]
Retrospective
for conventional
and propective
pro NPWT
38 pts
withNPWT vs.
28 pts closed
irrigation
Primary therapy failure,
in-hospital stay, in-
hospital, and 1 year
mortality
NPWT had lower failure of primary therapy
(5.8 vs. 39.2%, p<0.05), ICU stay (209.6±33.3
vs. 516.1±449.5 hours, p<0.01),and in-hospital
(5.8 vs. 21.4%, p<0.05) and 1-year mortality
(14.7 vs 39.2%, p<0.05), but comparable in-
hospital stay (40.2±16.3 vs. 48.8±29.2, NS)
with closed irrigation.
De Feo et al
[131]
Retrospective 74 pts NPWT
vs. 83 pts
closed
irrigation
Primary therapy failure,
in-hospital stay and
mortality
NPWT group with lower risk of therapy failure
(1.4 vs. 16.9%, p<0.001), shorter in-hospital
stay (23.3±9 vs. 3.0.5±3, p<0,05), and lower in-
hospital mortality (1.4 vs. 3,6 %, p<0,.05)
compared with closed irrigation
Assman et al
[132]
Retrospective 82 pts NPWT
vs. 38 closed
irrigation
In-hospital stay and
mortality
NPWT patients had shorter in-hospital stay
(45.6 ± 18.5 vs. 55.2 ± 23.6 dnů, p<0.05), and
lower in-hospital mortality (14.6 vs. 32.4 %,
p<0.05)
Vos et al [133] Retrospective 89 pts NPWT
vs. 24 open
packing
In-ICU and hospital stay
and mortality
NPWT led to shorter ICU stay (6.8±14.4 vs.
18.5±21.0 dnů, p<0.01), in-hospital stay
(74.4±61.2 vs. 69.1±62.7 days, p<0.01), and
lower in-hospital mortality (12.4 vs. 41.7%,
p<0.01)
Deniz et al
[134]
Retrospective 47 pts NPWT
vs. 43 pts
closed
irrigation
Primary therapy failure,
in-hospital stay and 1-,
3 years mortality
NPWT had insignificantly lower rate of primary
therapy failure (2.1% vs. 4.7%, NS) and shorter
in-hospital stay (18±9 vs. 24±10 days, NS), 90
days mortality significantly lower (8.5 vs.
23.2%, p<0.05) and better 1-, and 3-year
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survival (91.5% vs.76.7%, p<0,05, 87.2 vs.
69.8%, P<0.05)
Fleck et al
[135]
Retrospective 326 pts NPWT
vs. 198 closed
irrigation/
open packing
Primary therapy failure,
in-hospital mortality
NPWT was associated with lower primary
therapy failure (8.5% vs. 34% p<0.001), and
in-hospital mortality (3.6% vs. 10%, p<0.05)
Sjoegren at el
[18]
Meta-analysis 12 papers
focused on
comparison of
NPWT with
conventional
therapy
Primary therapy failure,
in-hospital stay and
mortality
NPWT associated with lower primary therapy
failure, shorter in-hospital stay, and lower in-
hospital and 1-year mortality
Raja et al [136] Meta-analysis 13 papers
focused on
comparison of
NPWT with
conventional
therapy
Primary therapy failure,
in-hospital stay and
mortality
NPWT seemed to be effective at high-risk
DSWI patients, but weak evidence for routine
first-line application in DSWI
Schimmer et al
[137]
Meta-analysis 15 papers
focused on
comparison of
NPWT with
conventional
therapy
Primary therapy failure,
in-hospital stay and
mortality, evaluation of
German hearts centers
protocols
NPWT is associated with lower therapeutic
failure, and in-hospital mortality. Routinely
applied as first-line treatment in 35% of
German heart centers
Damiani G et
al [138]
Meta-analysis 6 papers
focused on
comparison of
NPWT with
conventional
therapy and
chest
reconstruction
options
Primary therapy failure,
in-hospital stay and
mortality
NPWT prone to have shorter in-hospital stay
and lower mortality
Table 5. Analyses and Meta-analyse of comparison NPWT with conventional therapy
Addressing specific complications of DSWI, it is seen that NPWT does not increase the risk of
late infection recurrence. Reported rates of chronic fistulas after conventional therapy and
NPWT were comparable between 8-12% [18,130,134,140,41], and long-term survival of these
patients is negatively affected [140,142]. CONS was identified as a pathogen with a higher risk
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of recurrence; its low virulence, ability to create biofilm on metallic materials and inherent low
sensitivity against prophylactically administrated antibiotics limit its eradication [41,143].
With the rise in use of NPWT came an increased number of reported serious bleeding com‐
plications [144,145]. The risk of heart injury, particularly the right ventricle, bypass grafts or
great vessels is well known from conventionally treated patients. Infectious erosion, displace‐
ment of heart structures towards sternal margins, or tractions of fibrosis adhesion were
identified as potential mechanism of injury [146]. The incidence of these complications by
conventional therapy was found to be between 2-14.8% [147-149], with data from a larger
group of NPWT treated patients showing 2 to 5%, thus NPWT does not seem to increase the
incidence of serious complications [116,118,127,130,146,150]. Mortality from these complica‐
tions varies between 25 to 70%, with emergency surgery as well as proper covering of
mediastinal structures with interface dressing being crucial for management [146-148,150].
Several layers of paraffin gauze or silicone mesh are usually put below sternal margins on the
heart and grafts. Development towards more suitable material, particularly rigid barrier for
mediastinal protection is in progress, including mediastinal protection and preserved drainage
ability of therapy [151].
7. Reconstruction of sternal bone defect after DSWI in cardiac surgery
Wire re-cerclage was a commonly used method for addressing sternal approximation in
patients with sternal dehiscence after DSWI [72,86,102]. The quality of residual sternal bone
or its loss makes re-cerclage troublesome or even risky for achieving sternal stability. The
occurrence of extensive adhesions below the sternum in DSWI patients increases the risk of
damage to the right ventricle and bypass grafts when peri-, trans- and parasternal wiring
techniques are used [72,99,100]. Today, stable osteosynthesis of the sternum, particularly using
transverse plates, has become a method of treatment of post-DSWI sternal dehiscence [76].
Voss at el reported an institutional experience with Titanium Sternal Fixation system™ plates
for sternal non-union in 15 patients, in which four patients had more than two previous
attempts to stabilize the chest with some modification of wire re-cerclage, and four patients
were treated for DSWI with NPWT prior to plating. All patients were successfully stabilized
and healed, with one patient from the DSWI group experiencing a late infection recurrence
and one dying from a complication not related to plating [152]. Larger experience with the
same plate system has been reported by Baillot et al in a group of 92 patients after DSWI [46].
They achieved chest stabilization in all cases, with 9 patients (9.8%) undergoing further
procedure for late infection recurrence including removal of the plate with no impact on sternal
stability [153]. Chest stability after a healed DSWI improves respiratory function, augments
wound healing processes, shortens in-hospital stay, and improves patient quality [46,72,80].
Plating seems to be an effective method of chest wall stabilization, but may fail in cases of
massive loss of chest bone tissue. In these cases, the bone residue does not allow sufficient
anchoring for the plates or there is a large bone tissue gap. Shear forces may loosen screws and
threaten stability. Persistent pain and respiratory discomfort were also reported in this case
[154]. A conventional surgical approach to manage the large residual bone defect leaves the
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sternotomy wound unstable and employs the greater omentum or a muscle flap to fulfill any
dead spaces [93,95,99,103]. This approach resulted in sternal instability and flap-related
morbidity even when wounds were well-healed [154]. Some case reports have included the
use of an autologous bone iliac crest graft or allogenous fibula graft to supply residual bone
defects after DSWI [155,156]. Marulli reported the first use of an allogenous sternocostal bone
graft for sternal reconstruction after chondrosarcoma removal [157]. Consequently, Dell'amore
et al described four patients who were managed with the same technique with no wound
healing complications and preserved chest wall stability [158]. The same authors proposed this
technique for major post-DSWI defects, and [159] Kalab et al described the possibility of using
an allogenous calva bone graft to address this issue. Allogenous bony grafts being fixed with
transverse plates in mentioned cases [158-160]. Bone allograft usage for transplantation is
under law restriction of local governments and European Association of Tissue Banks
[161,162].
8. Options in soft tissue defects reconstruction after DSWI in cardiac
surgery
There are a broad range of possibilities for managing sternal soft tissue defects caused by
DSWI. In the case of minor defects, a direct suture with tissue undermining can be effective.
In wide dehiscence, some type of flap transfer is needed and excessive bone and soft tissue
loss are dependent on close co-operation between the cardiac and reconstructive surgeons.
There are two crucial conditions influencing the reconstructive strategy. The first condition is
the size of the defect, while the second is the vascular network, which would optimally remain
uncompromised after primary surgery or previously failed reconstructions. Although various
flaps and their modifications have been proposed, none have been found to be a reconstructive
option for all defects [97,163,164], therefore Greig et al suggested a simple classification system
to address the choice of flap based on the size and location of the post-sternotomy defect (Table
6) [165]. It is not possible, however, to follow this classification system because various factors
and conditions influencing the result must be taken into the account.
Wound type Site of sternal wound Recommended flap for reconstruction
Type A Upper half sternum Pectoralis major
Type B Lower half sternum Combined pectoralis major and rectus abdominis bipedicled flap
Type C Whole sternum Combined pectoralis major and rectus abdominis bipedicled flap
Table 6. Classification of sternal wounds according to anatomical site (modified from Greig et al [165])
In 1976, Lee et al were the first to report on the use of a pedicled greater omentum to fulfill the
large defect after total sternectomy [93]. In 1980, Jurkiewicz et al introduced the bilateral
pectoralis turnover flap for the same indication. Although various muscle flaps, along with
their modifications have been reported, there is still debate about using muscular versus
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cutaneous or fasciocutaneous flaps to cover difficult defects. It has been presumed that
muscular flaps carry richer vascular networks, thus bringing a better blood supply to the
defect, along with a higher antibiotic concentration. Recent studies, however, did not support
this hypothesis and suggested that muscle flaps have no particular advantage over fasciocu‐
taneous flaps in terms of improving vascularity and eradicating infection [166,167]. Never‐
theless, there is still a reasonable argument for muscular flaps as additional muscle brings
enough tissue for planed reconstruction.
8.1. The pectoralis major flap
The pectoralis major provides many qualities that make it a suitable flap choice for covering
sternal defects including close proximity to the sternotomy, triple blood supply (the thora‐
coacromial artery, perforating branches of the internal thoracic artery and the lateral thoracic
artery), and versatility of the flap as either the thoracoacromial or internal thoracic artery
vascular axis may be used separately to nourish the flap [168]. Netcher et al did not show an
adverse influence of the pectoral muscle transposition on pulmonary function [169], moreover,
pain and loss of strength appeared to be related more to sternal instability rather than to the
muscle transposition. Additionally, Cohen et al reported an improvement of spirometric
parameters (forced vital capacity and standardized forced expiratory volume in 1 second)
before and after pectoral flap transfer, thus supporting the crucial role of the flap in chest
stabilization [170].
8.1.1. Pectoral muscle advancement flap
The pectoral muscle advancement flap is based on the thoracoacromial pedicle and is consid‐
ered to be the best muscular reconstructive option in this area due to its technical simplicity,
versatility, and low risk of flap loss (<3%). There is, however, some risk of skin island necrosis
or partial necrosis (≈30%) [171, 172]. Dissection and elevation of the flap begins along the
median line of the costal grid until reaching the relatively avascular plane under the muscle.
Undermining then proceeds by blunt dissection laterally as necessary to achieve approxima‐
tion of the bilateral flaps at the median line without tension. The thoracoacromial vascular
pedicle is visible at the dorsal plane of the muscle. The humeral and clavicular insertion of the
muscle can be released if needed. If the distal portion of the sternum is exposed, dissection
continues distally under the anterior sheet of the rectus abdominis which then becomes part
of the flap [164]. Though the flap is elevated mostly in a myocutaneous fashion
[73,163,164,173,174], Brutus et al reported on the use of a pectoral muscle flap released from
skin for covering the entire sternal defect [175]. Completely dissected and freed from all of its
origins, the pectoral muscle was advanced medially on the skeletonized vascular pedicle to
cover the full length of the sternal defect. Separating the skin from the muscle can jeopardize
the cutaneous blood supply and increase risk of skin necrosis. This technique included the
release of humeral insertion from a short skin counter incision [175].
If the defect is wide, it may be difficult to achieve tension-free suturing in the midline. A
modification of the advancement flap with a skin relaxing incision has been reported [176].
Majure et al proposed shifting the skin island over the pectoralis muscle in the V-Y manner to
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cover the entire sternotomy defect, but this method requires secondary skin grafting from an
island donor site [177]. This technique was adopted and modified by Molitor et al [178]. The skin
island is dissected, while the underlying muscle fascia and pectoralis major are elevated and
completely released from their insertions to the humerus, sternocostal junctions and abdomi‐
nal muscles. The thoracoacromial vessels are visualized and the clavicular insertion of the muscle
is released to achieve comfortable advancement of the flap to the defect. The secondary defect
in the lateral thoracic wall is then sutured in the V-Y manner and no skin graft is needed [178].
Finally, the pectoralis major musculocuteneous flap can be mobilized in a rotational manner
when the skin-muscle flap is elevated based on the thoracoacromial pedicle and is rotated to
the defect [179].
8.1.2. Pectoral muscle turnover flap
This flap is based on perforators of the internal mammary artery. Once the skin is elevated off
of the anterior pectoralis fascia, the distal rib, proximal clavicular origin and humeral insertion
of the muscle are divided. Then, the thoracoacromial pedicle is dissected and ligated, and the
pectoralis major is elevated from lateral to medial until the perforating vessels from the internal
thoracic artery are identified, and the muscle is then turned into the defect. To gain additional
width of the narrowing humeral portion of the flap, fascial release incisions along the direction
of the muscle fibers can be done. By this maneuver an average increase in flap width of 5.8 cm
can be obtained [181]. Usually bilateral turnover muscle flaps are used [94,95]. The disadvan‐
tages of this flap include limitations in the distal parts of the sternum, need for wide skin
undermining, dependence on an intact internal mammary artery, and an unfavorable aesthetic
consequence including a missing anterior axillary line and parasternal subcutaneous tissue
bulkiness [95].
8.2. The rectus abdominis flap
This flap was first used in cardiac surgery by Jurkiewicz in the case of a pectoral turnover flap
failing to cover the entire defect [94,95]. To cover the sternal defect, the rectus abdominis flap
is used exclusively as a pedicled flap based on the superior epigastric artery [182]. Because this
artery is the terminal branch of the internal thoracic artery, the flap cannot be used if the
ipsilateral internal thoracic artery was used for bypass grafting. The functional consequences
of using the rectus abdominis to reconstruct sternal defects were assessed by Netscher et al
[169]. They found no significant differences in abdominal wall function between the groups
of patients in whom the rectus muscle was used for reconstruction and the group without
sternal wound complications. There is a higher associated risk of hernia (11%) or fascial
weakness (42%) as was reported [103,183]. The rectus abdominis flap may be used as a
muscular flap [94,184) or as a myocutaneous island flap [171,185].
8.2.1. Rectus abdominis muscular flap
The rectus abdominis muscular flap may be dissected without the use of a skin island. The
skin incision continues distally to the desired point according to the necessary flap length. The
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skin is undermined over the rectus fascia to expose the muscle. Then, the rectus anterior sheet
is divided and the muscle is dissected and mobilized. The distal pedicle inferior epigastric
vessels are ligated and divided. The muscle is then turned to the defect. The exposed muscle
and pedicle is covered either by skin suture or grafting [95].
8.2.2. Rectus abdominis musculocutaneous flap
The myocutaneous flap can have a skin island oriented vertically along the used muscle (VRAM-
vertical rectus abdominis muscle flap), or horizontally, as well as perpendicular to the muscle
distal  to  the umbilicus (TRAM-transverse rectus abdominis  muscle  flap).  The transverse
orientation permits harvest of a larger skin paddle. Dissection of the VRAM starts with marking
the skin island over the used muscle. The skin component should be placed medially near the
umbilicus to include important periumbilical perforators. The skin island is cut and the skin
overlying the muscle is undermined above the muscle fascia. Then, the rectus sheet is divided
bilaterally at the edges of the muscle and the muscle is dissected and mobilized. The distal pedicle
inferior epigastric vessels are ligated and divided. The flap is then turned to the defect. The TRAM
is marked transversely under the umbilicus and skin island which can involve the entire area
between the umbilicus and symphysis bilaterally. The flap is dissected in the similar way as the
VRAM flap, but the mobilization of the skin island continues away from the muscle pedicle
crossing the midline to the contralateral side [171,185]. Care must be taken to avoid pedicle
compression passed through the subcutaneous tunnel to the sternal defect.
8.3. Combined pectoral muscle — Rectus abdominis muscle flap
For full length sternal defects, a combined pectoralis major and rectus abdominis flap (Pec-Rec
flap) was proposed [186]. The flap is predominantly created on the left side, but can occasional‐
ly be bilateral. The skin overlying the pectoral muscle is elevated up to the mid-axillary line
laterally and from the clavicle to the inferior costal line in a vertical direction. The pectoral muscle
is elevated while preserving the thoracoacromial vessels. The muscle is detached from its humeral
insertion and medially from one third of the clavicle. Dissection of the flap continues distally
while elevating the thoracoepigastric fascial attachments from the chest wall between the
pectoralis major and the rectus abdominis. Distal to the fascia, the anterior sheet of the rectus
abdominis is incised medially and laterally and the muscle is mobilized from the posterior fascia.
The muscular connections of the rectus abdominis to the distal ribs are detached as the last step
of flap harvesting. The superior epigastric artery can be preserved or it can be divided close to
the muscle if necessary for better medial transposition of the flap [186].
8.4. The latissimus dorsi muscle flap
The latissimus dorsi flap is based on a thoracodorsal artery that has not been jeopardized by
previous cardiac surgery. Moreover, a large flap can be harvested (the main surface area of
muscle is 105 cm2 for women and 192 cm2 for men) [187]. The main disadvantages of this flap
include the need for a lateral decubital position during flap harvesting that can endanger
patients with large sternal bone defect and sternal instability and shoulder functional limita‐
tion followed latissimus dorsi muscle harvesting. Patients who are dependent on their
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shoulder girdle strength, such as paralytic patients in a wheelchair or walker dependent
patients, may endorse strength difficulties after muscle harvesting as well as tennis and golf
players or those whose profession involves overhead tasks [187]. Up to 50% of patients may
complain of localized numbness at the harvesting area [172].
Usually the muscle from the non-dominant side is used. The arc of rotation and position of the
skin island is assessed and marked. The skin component is predominantly oriented perpendic‐
ular to the muscle fibers near the vertebral column, but a longitudinal course from the medial
axillary line to the medial caudal dorsum is also possible. The flap is dissected using the whole
muscle up to the pedicle. Thoracodorsal vessels are skeletonized and humeral muscle inser‐
tion is divided, allowing an additional 4-10 cm of flap advancement. Then the flap is trans‐
posed to the defect through a subcutaneous tunnel superficial to the pectoralis major [188,189].
8.5. Breast flap
Obese female patients with large breasts are at higher risk of sternal dehiscence due to the
infero-lateral tension of the breasts, especially on the distal third of the sternotomy [72].This
instability results from the greater protrusion of the lower thorax and abdomen during
respiration, greater dimensions of the lower versus the upper thorax, the concentration of
forces from the attachment of the ribs, and the reduced thickness of the lower sternum [72].
Therefore a special bandage, supporting bra, or other garment is used to release the tension
resulting from large breasts. The technique of covering the sternal dehiscence with a bilateral
pectoral muscle advancement flap with simultaneous breast reduction has been reported
[190-192]. Large breasts carry an enormous amount of relatively well vascularized tissue that
can potentially be used to cover the sternal defect [193,194]. The vascular supply of the breast
is basically the same as the pectoral muscle. There is, however, a unique vascular network
inside the breast gland, known as Würinger´s septum. Uygur et al reported a method of
covering a large distal sternum defect with bilateral fasciocutaneous V-Y flaps from the breasts
[193]. These flaps were anatomically based on the Würinger´s septum [193,195]. Another
method has been suggested by Hamdi et al [196]. They performed a septum-based therapeutic
mammoplasty on two patients. The principle of this technique is to reduce breast mass with
harvesting of a large fasciocutaneous flap from the inferomedial part of the breast
Another possibility for utilizing the breasts to cover the sternal defect is a Cyclops´ flap. In this
technique the whole breast is transposed to the central or even contralateral chest defect, so
that the areola is centralized. The breast flap in this case is based on the lateral and central
vascular pedicles of the breast [197,198].
8.6. Omentum
The greater omentum is a well-vascularized tissue with plentiful lymphatic drainage and
angiogenic activity [93,98,199]. Its size can be up to 36x46 cm and is reliable to cover large
defects. It is difficult, however, to predict the flap size preoperatively because the greater
omentum volume has no direct correlation with the patient’s habitus [200]. The omentum can
be transposed to the defect in various ways such as, pedicled on both gastroepiploic arteries
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for defects in the distal part of sternotomy wound or mobilized on either of the gastroepiploic
vessels to cover full-length sternotomy defects [201-203]. Passing the omental flap subcutane‐
ously from the upper portion of the laparotomy bears up to a 21% risk of late herniation [202],
thus, a better solution seems to create the transdiaphragmatical tunnel just right of the falciform
ligament [204]. The risk of abdominal cavity infection is rare [205], but the traction on the
gastroepiploic artery can cause motility disturbances of the stomach and duodenum [206], and
one case of fatal cecum volvulus have been reported [207]. Laparoscopic harvesting seems to
be promising in reduction of access complications and pain [108,208,209].
8.7. Microsurgical flaps
Microsurgical free flaps can be used to cover sternal defects in particular situations. This
technique, due to its duration and technical complexity, should serve as a last treatment option.
The use of the tensor fascia lata myocutaneous flap, rectus abdominis myocutaneous flap and
deep inferior epigastric artery fasciocutaneous flap for this indication have been reported [210].
As a donor vessel, the thoracoacromial, internal thoracic or cervical vessels can be used. The
cephalic vein attached to the thoracoacromial or cervical arteries, can be used for lengthening
the donor vessel (arterio-venous loop) [210,211].
8.8. Specifics of care after flap surgery in cardiac surgery
There are special requirements for care after flap surgery. In general, it is important to protect
the blood circulation within the flap, maintaining both general and local hemodynamics.
Vascular spasm must be prevented by using vasodilator drugs if possible. The elevated and
transposed flap usually loses most of its physiological blood and lymphatic network and is
dependent only on a small part of it, so varying degrees of edema are usually present. Large
swelling of the tissue compresses the capillaries and decreases the blood flow in the flap,
increasing the tension on the suture. Corticosteroids are used to prevent swelling for several
days in most flap surgeries unless serious contraindications are present. The flap must be kept
from topical pressure, particularly in places of passing vascular pedicle and in peripheral parts
of the flap because of limited vascular competence. Undoubtedly, changes in body position
influence the blood supply of the flap. Furthermore, stretching of the arms causes increased
tension on the medial sternal suture. In the case of the pectoral and latissimus dorsi flap, the
use of muscles of the shoulder girdle should be avoided. When using the rectus abdominis
flap, the abdominal wall must be relaxed and supported with bandages for several weeks to
prevent hernia formation. Finally, nutritional support with enteral feeding is essential for
successful healing.
9. University hospital Olomouc management of DSWI after cardiac surgery
9.1. Adopted treatment strategy for DSWI
We retrospectively analyzed our experience with treatment strategies of DSWI since February
2002, when our department was established. A total of 100 patients fulfilling CDC criteria [5]
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for DSWI were enrolled until September 2011 with an overall incidence of DSWI of 1.36%. The
results of 28 patients (March 2002-June 2004) primarily treated with closed chest irrigation
using diluted iodine solution were compared with 76 patients (September 2004 to September
2009) treated with NPWT (VAC ATS™, KCI, St. Antonio, USA). A standardized protocol for
first-line application of NPWT is depicted in Figure 1. Six patients from the interim period
(June to September 2004) when closed irrigation and NPWT were combined were excluded
from the analysis. Both groups had comparable demographic and perioperative characteris‐
tics, however, the NPWT arm had an insignificant trend towards advanced age, higher logistic
EUROSCORE, more complex primary cardiac surgery. No difference in the rate of causative
agent was found, with SA and CONS identified in almost 70% of cases. Escherichia coli (5.8%)
and Pseudomonas species (7.2%) as leading Gram negative strains were cultivated. The time
to presentation of DSWI was insignificant between groups (17.5±15.0 vs. 13.8±16.3, p=0.55) as
well as readmission for late clinical presentation of DSWI (38.6% vs. 50%, p=0.12). Although
the overall length of DSWI therapy was comparable (14.3±11.9 vs. 14.9±7.9 days, p=0.82),
NPWT required more dressing changes (5.4±2.3 vs. 1.8±1.2, p<0.001), but was associated with
substantially lower failure of primary therapy (5.1 vs. 39.2%, p<0.01) with closed chest
irrigation. In-ICU stay was significantly shorter in the NPWT group (209.6±331.3 vs.
516.1±449.5 hours, p<0.001), nevertheless, shortened in-hospital stay (40.2±16.3 vs. 48.8±29.2
days, p=0.16) was insignificant in this group. Addressing mortality, 30-day and 1-year
mortality was considerably lower in the NPWT arm (3.9 vs. 21.4%, p<0.05, 15.8 vs. 39.2%,
p<0.05, respectively). A Kaplan-Meier 1 year-survival analysis is shown in Figure 2. The risk
of major bleeding complications was comparable between groups, with 2 patients (3.6%) from
the closed chest irrigation group having erosion of venous bypass graft and right ventricle
(RV), and 3 patients (3.9%) from the NPWT group, including 1 debridement-related and 2
spontaneous injuries of the RV. Employment of local and advancement flaps for covering of
residual defects was higher in the NPWT groups (65.7 vs. 17.8%, p<0.01). Our experience
showed that NPWT is effective in the treatment of DSWI, compared with closed chest
irrigation, leading to lower failure of primary therapy, ICU stay, and better short- and mid-
survival of patients. We did not prove NPWT influenced length of in-hospital stay or risk of
major bleeding, however, residual defects required more complex approach to assure sternal
stability and covering defects [119,130].
9.2. Sternal stabilization and management of residual bone defects
Non-complicated sternal dehiscence following DSWI that is not associated with considerable
bone loss can be stabilized with transverse titanium plates (Titanium Sternal Fixation system™,
Synthes, Switzerland) at our department. Plates are applied on the anterior surface of the
ribcage to achieve sufficient stability of the chest wall while minimizing the risk of an iatrogenic
injury to the heart. From January 2008 to September 2012 we performed 31 sternal wall
reconstructions using the Titanium Sternal Fixation system™. In four cases, osteosynthesis
was applied to treat a sterile mechanical dehiscence of the median sternotomy, while 27 other
chest osteosyntheses were performed after DSWI when wound bed decontamination was
achieved with NPWT. In the postoperative period, 2 patients (7.4%) needed to be operatively
revised due to bleeding from pectoral flap advancement; in 3 cases (11.1%) the plates needed
Current Challenges in the Treatment of Deep Sternal Wound Infection Following Cardiac Surgery
http://dx.doi.org/10.5772/55310
513
to be removed for soft tissue healing complications post-reconstruction. Nevertheless, removal
could be postponed until satisfactory healing of the sternal bones was achieved. One patient
(3.7%) had to be drained for iatrogenic pneumothorax. We also retrospectively analyzed 21
patients with post-DSWI sternal dehiscence from January 2005 to January 2010, comparing 11
patients with re-cerclage wiring and 10 patients with titanium plate osteosynthesis. DSWI was
managed with the same protocol of NPWT prior to reconstruction mentioned above [119].
Plating was accompanied by a lower risk of therapy failure (1% vs. 1.85%), shorter in-hospital
stay (22 vs. 59%), and reduction in costs ((€8,243 vs. €33,365) (unpublished data).
In cases of minor sternal bone loss, we use an autologous bone graft harvested from the
patient ´s own iliac crest. The graft is preferably prepared as bi-cortical. There is a limit to
the extent of bone tissue that can be solved through this method. Fixation of the bone graft
and chest stabilization is done in the manner described above. From 2009 to 2012 we used
this method in 2 patients. In both cases the wounds healed successfully and the sternal wall
regained full stability. Both sternal defects represented partial loss of bone tissue from 6 to
8 cm in length.
Based on this experience, we decided to apply a novel approach for the treatment of massive
bone loss after DSWI, by supplying the bone defect with an allogenous bone graft. It allows
Figure 1. The first-line application protocol of NPWT for treatment of DSWI
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treating large sternal defects in the same way as a total or near-total sternectomy and fixed
properly with titanium plate system ensures chest cage stability. An allogenous bone trans‐
plant doesn´t contain any vital bone marrow cells, which eliminates difficulties in immuno-
genetic acceptance of the graft by a patient; it represents a biological tissue transfer, which
even under conditions of maximum precautions represents a minor risk for transmission of
viral or bacterial infections. An allogenous graft must meet legislative criteria from the Czech
Republic and the European Association of Tissue Banks [161,162]. Prior to graft harvesting,
each donor is cross-checked for registration within the National Registry for organ donation
refusal. All deceased donors treated for infectious disease, sepsis, malignant tumors, or
systemic and autoimmune diseases at the time of death are withdrawn from the donor list.
Donor blood serum samples are tested for antibodies and HIV types 1 and 2, hepatitis B surface
Figure 2. 1-year Kaplan-Meier survival analysis comparing NPWT with conventional therapy (CONV)
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antigen (HbsAg), hepatitis C antibodies (anti-HCV), and HTLV I and II antibodies. Harvest of
a sternal bone graft is performed under strictly sterile conditions by a team from the National
Tissue Center in Brno. The graft is harvested under sterile conditions and stored in the freezer
at −80°C. Prior to its clinical use, the graft is thawed at 4-6°C for 12 hours, soaked with a 1%
gentamicin solution, prepared for its final shape, and stored in the freezer again at −80°C. If
bacterial sampling is negative, the graft is thawed for 12 hours before transplantation, and
submerged in a bath with 1% neomycin solution immediately before surgery.
Inherent surgical technique is modified by a more aggressive debridement of residual chest
bone or ribs (1-2 cm safety line). Afterwards, the bone graft is adjusted to the size of the bone
defect and fixed with plates anchored by self-cutting or self-drilling cortical screws. An uneven
surface and tiny bone deficiency can be filled in with a spongy bone which is prepared from
another graft provided by the tissue bank (femoral or tibial graft source). Residual soft tissue
defect is covered with monolateral or bilateral pectoral muscle flap transfer. Within the
postoperative period, it is strongly recommended to avoid excessive coughing or any rough
mechanical strain on the sternal wall. Intravenous antibiotics are administered for at least three
weeks after the reconstruction. Between January 2010 and September 2012, we performed six
reconstructions of the sternal wall using an allogenous bone graft. We used a cadaveric
sternum in four cases (Figure 3), and due to a lack of allografts, we had to use a calva bone in
one patient (Figure 4) and a split femoral diaphysis in one patient. Successful healing after the
reconstruction was achieved in five cases (83%), while one patient required additional
treatment for partial skin necrosis. One obese female experienced flap failure and died from
multiple organ failure. Follow-up of the other patients at 3, 6 and 12 months after reconstruc‐
tion proved stability of the chest wall. A radio-isotope scan using technetium as a tracer of
autologous leukocytes (Technetium-HMPAO) carried out at 3, 6 and 12 months after the
reconstruction showed a high level of healing activity within the area of the allogenous bone
implant, and further chest wall stability with allograft union was confirmed through 3D-CT
evaluation done 5 to 7 months after the reconstruction (unpublished data).
Figure 3. Cadaveric sternal allograft and its use for large residual bone defect
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Figure 4. Cadaveric calva bone allograft in large bone defect repair and CT reconstruction showing the bone re-union
9.3. Reconstruction of residual soft tissue defects
In a group of 76 consecutive patients primarily treated with NPWT for DSWI from September
2004 to September 2011, 19 residual defects (25%) were closed by direct suture, and 57 patients
(75%) underwent flap transfer to achieve reliable tension-free suture. All but 2 patients (2.7 %)
underwent sternal stabilization with re-cerclage (61.8%) or transverse plates with or without
bone graft (35.5%). Local fasciocutaneous advancement was used in 12 patients (21.1%),
bilateral pectoralis advancement flap in 35 patients (61.2%), monolateral pectoralis flap with
V-Y skin island in 7 patients (12.3%), bipedicled pectoral and rectus abdominis flap in 1 patient
(1.7%), and vertical rectus abdominis flap in 2 patients (3.5%). We faced 2 flap failures (3.5%)
and one whole monolateral pectoralis flap with V-Y skin island was lost due to vascular pedicle
thrombosis, with 50% of the mass of the VRAM flap needing to be removed for flap necrosis.
Minor healing complications requiring further local wound care were noted in 15 cases (26.3%).
While the bilateral pectoralis advancement flap is a technique used by cardiac surgeons, other
flaps used for covering larger residual soft tissue defects are utilized by plastic surgeon. The
pectoral major flap with V-Y skin island is the first choice (Figure 5). When the defect is wide
and deep, or in a female patient with large breasts, the VRAM pedicled flap is considered. If
these two options fail or are not accessible, the latissimus dorsi pedicled flap is the next choice,
and as a last resort, the microsurgical transfer is taken into account.
Figure 5. Technique of unilateral pectoral muscle flap advancement with V-Y skin island
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10. Conclusion
DSWI remains a potentially fatal complication of cardiac surgery. Even though risk factors for
development of DSWI have been identified, few are modifiable. Tight perioperative glycemic
control, proper surgical technique, skeletonization of IMA grafts particularly in diabetics, and
primary stable sternal approximation for high risk patients including diabetics, obese,
immunosuppressed or those with COPD seem to reduce the risk of DSWI. Thanks to the unique
combination of closed and open chest treatment, NPWT positively influences the survival of
DSWI patients even at long-term follow-up in comparison with conventional therapy.
Transverse titanium plates alone or with auto- or allograft bone allows chest cage stability
irrespective to the bone mass loss. Better quality of life and lower extent of soft tissue defect
might be promising for these patients who faced sternal instability and considerable flap-
related morbidity some/few years ago. Plastic surgeons should be included in team planning
post-DSWI sternotomy wound closure, not only called when previous closure attempt failed
or residual defect seems to be extent.
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